Strong words from Dr Nicola Dean but well founded. AHPRA leadership is failing to understand or respond to a destructive group of rogue practitioners who are harming our community. smh.com.au/national/this-…

Fantastic initiative NCI Center for Global Health. In our work on cancer in Africa we consistently hear that stigma is a major driver of late presentations and poor outcomes.

This may resolve our decade old discussion about the correct use of “comprise” Erica Wood !

Saddened to learn of the death of David Bailey, Canada's first four-minute-miler and the scientist who discovered, by sheer serendipity, that grapefruit juice interacts with dozens of medications. I'll tell the story as David related it to me. theglobeandmail.com/canada/article… /1

Another brilliant concept on the frontier of health ageing and generational learning, from the inimitable Stephanie Ward

Brilliant keynote from Isabelle BOUTRON at @ictmc2022 reminding us of researcher responsibility in fair and transparent reporting of trials. Manuscript spins flows to PR spin flows to the news… as we have seen in COVID sometimes with adverse real world consequences…

A thoroughly excellent night at the ANU Classics Museum. Dr Georgia Pike-Rowney and Caillan Davenport gave a special ANU Medicine and Psychology tour of the collection, including the opportunity to hold some objects!

‘If we’re going to fail, let’s fail more quickly’. And if we’re going to succeed, let’s succeed quickly. Max Parmar on why trial platforms are vital for speeding up the the way treatments are tested, inc. for prostate cancer & dementia. #ICTMC2022 #cancer #RCTs #dementia

A tour de force from Max Parmar MRC Clinical Trials Unit at UCL on platforms and multi-arm multi-stage trails - statistical, practical, political considerations. To quote one of his patient partners, why aren’t all trials done this way? @ictmc2022

Honoured to be in such esteemed and diverse company with other investigators ourANU John Curtin School of Medical Research, ANU and across the country thanks to NHMRC #globaloncology #clinicaltrials #immunotherapy

Ensuring grants meet a minimum standard and then randomising outcomes could improve diversity and innovation, reducing status bias in assessment Financial Times on.ft.com/3D7b4oX

“Australia needs a highly educated population; it needs ground-breaking research and an ecosystem where government, industry and academia work together to propel people and ideas towards a common societal good.” ⁦Brian P Schmidt⁩ on our universities theguardian.com/commentisfree/…

"Without the NDIS I would probably still be living with my parents.. what the NDIS is, is an enabler for a better life for a lot of Australians and I think that humanity of the conversations needs to never be lost when we talk about it" - Dr Ben Gauntlett

Congrats to Prof Mark Polizzotto Mark Polizzotto on being awarded the Tony Ayers Award for Excellence in Research in Translational Medicine.💊 Mark will give a public lecture on Simple Therapies for Global Oncology at ourANU on 24 Nov. Register at eventbrite.com.au/e/tony-ayers-l… to join us!

Today we get together with our colleagues and friends to celebrate #LGBTQIASTEMDay and learn how to be an active ally via an awesome @franklinwomen webinar presented by Dr Erin McGillick. Join us to mark the day by appreciating the benefits diversity brings to STEM!🌈 #wearejcsmr

Congratulations Kathy Petoumenos ! Wonderful to see recognition of this international leader, valued colleague and thoughtful mentor.